Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial
Journal
-
- The Lancet Oncology
-
The Lancet Oncology 15 (12), 1369-1378, 2014-11
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360855569085580672
-
- ISSN
- 14702045
-
- Data Source
-
- Crossref